(Q64352402)
Statements
Post-marketing Clinical Study of Gabapentin Enacarbil ―Non-blinded Study in Restless Legs Syndrome (RLS) Patients With Moderate Renal Impairment― (English)
0 references
5 November 2013
0 references
13 May 2015
0 references
19
0 references
20 year
0 references
80 year
0 references